2026.05.27
Q&A on Japan’s Conditional Approval Policies for Pharmaceuticals: Key Clarifications for Global Drug Developers
Introduction to Japan’s Conditional Approval Q&A According to the Q&A document issued by Japan’s Minis […]
2025.02.27
Astellas Seeks Conditional Approval in Japan for Geographic Atrophy Treatment Without Japanese Patient Data
Introduction to Astellas’ Pioneering Regulatory Submission According to the news (News | Astellas Pharma Inc.) […]